Public Employees Retirement System Of Ohio Century Therapeutics, Inc. Transaction History

Public Employees Retirement System Of Ohio

$22.6 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.46 - $4.05 $10,432 - $17,176	-4,241 Reduced 97.7%	100 $0
Q1 2024 May 15, 2024	BUY	$3.19 - $5.32 $13,847 - $23,094	4,341 New	4,341 $18,000
Q1 2023 May 15, 2023	BUY	$3.4 - $5.11 $29,699 - $44,635	8,735 New	8,735 $30,000

Others Institutions Holding IPSC

# of Institutions

Shares Held

36.9M

Call Options Held

8.7K

Put Options Held

10.2K

Bain Capital Life Sciences Investors, LLC Boston, MA

5.41M
Shares

$6.55 Million
1.66% of portfolio
Vr Adviser, LLC New York, NY

5.39M
Shares

$6.52 Million
0.95% of portfolio
Boxer Capital, LLC San Diego, CA

3.9M
Shares

$4.72 Million
0.35% of portfolio
Casdin Capital, LLC New York, NY

3.21M
Shares

$3.89 Million
0.43% of portfolio
Black Rock Inc. New York, NY

2.9M
Shares

$3.5 Million
0.0% of portfolio

View Full List

About Century Therapeutics, Inc.

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $71.2M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

More about IPSC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account